1
Daniel D Von Hoff, Robert J Penny: System and method for determining individualized medical intervention for a disease state. Caris MPI, Ramin Akhavan, December 16, 2014: US08914239 (9 worldwide citation)

A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene ...


2
Daniel D Von Hoff, Robert Penny: System and method for determining individualized medical intervention for a disease state. Caris MPI, Ramin Akhavan, April 15, 2014: US08700335 (8 worldwide citation)

A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene ...


3
Daniel D Von Hoff, Robert J Penny: System and method for determining individualized medical intervention for a disease state. Caris MPI, Ramin Akhavan, September 9, 2014: US08831890 (8 worldwide citation)

A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene ...


4
Daniel D Von Hoff, David M Loesch, Arlet Alarcon, Robert J Penny, Alan Wright, Matthew J McGinniss, Ryan P Bender, Traci Pawlowski: Molecular profiling of tumors. Caris MPI, Ramin Akhavan, June 23, 2015: US09064045 (5 worldwide citation)

Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a trea ...


5
Daniel D Von Hoff, David M Loesch, Arlet Alarcon, Robert J Penny, Alan Wright, Matthew J McGinniss, Ryan P Bender, Traci Pawlowski: Molecular profiling of tumors. Caris MPI, Ramin Akhavan, June 9, 2015: US09053224 (5 worldwide citation)

Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a trea ...


6
Daniel D Von Hoff, David M Loesch, Arlet Alarcon, Robert J Penny, Alan Wright, Matthew J McGinniss, Ryan P Bender, Traci Pawlowski: Molecular profiling of tumors. Caris MPI, Ramin Akhavan, July 28, 2015: US09092392 (5 worldwide citation)

Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a trea ...


7
Daniel D Von Hoff, David M Loesch, Arlet Alarcon, Robert J Penny, Alan Wright, Matthew J McGinniss, Ryan P Bender, Traci Pawlowski: Molecular profiling of tumors. Caris MPI, Ramin Akhavan, June 16, 2015: US09058418 (5 worldwide citation)

Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a trea ...


8
David D Halbert, Christine Kuslich, George Poste, Michael Klass, David Spetzler, Traci Pawlowski, Andrea Tasinato, Daniel Holterman: Biomarkers for theranostics. Caris Life Sciences Switzerland Holdings, Ramin Akhavan, September 8, 2015: US09128101 (3 worldwide citation)

Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. Th ...


9
Christine Kuslich, George Poste, Michael Klass, David Spetzler, Traci Pawlowski: Circulating biomarkers for metastatic prostate cancer. Caris Life Sciences Switzerland Holdings, Ramin Akhavan, October 18, 2016: US09469876 (2 worldwide citation)

Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. Th ...


10
Daniel D Von Hoff, David M Loesch, Arlet Alarcon, Robert J Penny, Alan Wright, Matthew J McGinniss, Ryan P Bender, Traci Pawlowski: Molecular profiling of tumors. Caris MPI, Ramin Akhavan, July 12, 2016: US09389234 (2 worldwide citation)

Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a trea ...